History | Infliximab for the treatment of adults with psoriasis | Guidance | NICE

History

A list of downloadable documents created during development.

Background information

Psoriasis - infliximab: Final appraisal determination and comments on ACD

Psoriasis - infliximab: Final appraisal determination and comments on ACD information
Psoriasis - infliximab: Final appraisal determination ^{PDF 86 KB} 30 November 2007
Response to consultee, commentator and public comments on the ACD and comments from website consultation ^{PDF 137 KB} 30 November 2007
Consultee and commentator comments on the ACD
Commentators
Wyeth Pharmaceuticals ^{PDF 60 KB} 30 November 2007
Merck Serono ^{PDF 32 KB} 30 November 2007
Cochrane Skin Group ^{PDF 9.5 KB} 30 November 2007
Professional and patient groups
Royal College of Physicians ^{PDF 63 KB} 30 November 2007
Royal College of Paediatrics and Child Health ^{PDF 12 KB} 30 November 2007
The Psoriasis Association ^{PDF 25 KB} 30 November 2007
British Association of Dermatologists ^{PDF 16 KB} 30 November 2007
Schering Plough Ltd ^{PDF 423 KB} 30 November 2007
Expert comments on the ACD: Ms Karina Jackson, Clinical Expert nominated by the British Dermatological Nursing Group ^{PDF 40 KB} 30 November 2007

Psoriasis - infliximab: Appraisal Consultation Document

Psoriasis - infliximab: Appraisal Consultation Document information

Psoriasis - infliximab: Evaluation report

Psoriasis - infliximab: Evaluation report
Psoriasis - infliximab: Schering-Plough Ltd ^{PDF 1.59 MB} 03 September 2007
Psoriasis - infliximab: Evidence review group report ^{PDF 445 KB} 03 September 2007
Pre-meeting briefing ^{PDF 175 KB} 24 August 2007
Psoriasis - infliximab: Non-manufacturer submissions
The Psoriasis Association ^{PDF 54 KB} 24 August 2007
Psoriatic Anthropathy Alliance ^{PDF 45 KB} 24 August 2007
British Association of Dermatologists ^{PDF 51 KB} 24 August 2007
British Dermatological Nursing Group ^{PDF 42 KB} 24 August 2007
Royal College of General Practitioners ^{PDF 16 KB} 13 September 2007
Royal College of Physicians ^{PDF 44 KB} 24 August 2007
Psoriasis - infliximab: Manufacturer response to clarification letter
Manufacturer response A ^{PDF 239 KB} 24 August 2007
Manufacturer response B ^{PDF 735 KB} 24 August 2007
NICE clarification letter ^{PDF 27 KB} 22 August 2007
Psoriasis - infliximab: Expert written personal statements
Griffiths ^{PDF 20 KB} 24 August 2007
Barker ^{PDF 22 KB} 24 August 2007
Jackson ^{PDF 23 KB} 24 August 2007
Edwards ^{PDF 21 KB} 24 August 2007
Jobling ^{PDF 20 KB} 24 August 2007

Medicines concordance: Final scope

Medicines concordance: Final scope ^{PDF 39 KB} 14 June 2007

Medicines concordance: Final scope

Medicines concordance: Final scope ^{PDF 39 KB} 14 June 2007

Comments on draft scope and matrix and the Institute's response

Comments on draft scope and matrix and the Institute's response ^{PDF 51 KB} 09 March 2007

Psoriasis - infliximab: Final scope archive

Medicines concordance: Final scope ^{PDF 39 KB} 14 June 2007

Psoriasis - infliximab:Appraisal consultation document (using ACD form features)

Psoriasis - infliximab:Appraisal consultation document (using ACD form features) information